News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tesaro, Inc. Seeks $86.2 Million IPO



3/27/2012 7:48:21 AM

TESARO Inc., a Waltham, Mass.-based biotech licensing and developing cancer therapies and oncology supportive care products, has filed for an initial public offering of stock with the aim of raising $86.2 million. The firm last June raised $101 million in a Series B round led by West Coast venture firm Kleiner Perkins Caulfield & Byers, and other backers include New Enterprise Associates, which took part in a $20 million Series A that launched the firm in 2010. TESARO is seeking to trade on the Nasdaq under the symbol "TSRO." Underwriters include Citigroup, Morgan Stanley and Leerink Swan.

Read at Mass High Tech
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES